Global Infectious Disease Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Infectious Disease Diagnostics market size was valued at USD 3749.5 million in 2023 and is forecast to a readjusted size of USD 4972.4 million by 2030 with a CAGR of 4.1% during review period.
Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
The Global Info Research report includes an overview of the development of the Infectious Disease Diagnostics industry chain, the market status of Hepatitis C (Molecular Diagnostic Technique, Traditional Diagnostic Technique), Hepatitis B (Molecular Diagnostic Technique, Traditional Diagnostic Technique), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Disease Diagnostics.
Regionally, the report analyzes the Infectious Disease Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Disease Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infectious Disease Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Disease Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Molecular Diagnostic Technique, Traditional Diagnostic Technique).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Disease Diagnostics market.
Regional Analysis: The report involves examining the Infectious Disease Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Disease Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infectious Disease Diagnostics:
Company Analysis: Report covers individual Infectious Disease Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Disease Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis C, Hepatitis B).
Technology Analysis: Report covers specific technologies relevant to Infectious Disease Diagnostics. It assesses the current state, advancements, and potential future developments in Infectious Disease Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Disease Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin and global market share of Infectious Disease Diagnostics from 2019 to 2024.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Disease Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Diagnostics.
Chapter 13, to describe Infectious Disease Diagnostics research findings and conclusion.
Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
The Global Info Research report includes an overview of the development of the Infectious Disease Diagnostics industry chain, the market status of Hepatitis C (Molecular Diagnostic Technique, Traditional Diagnostic Technique), Hepatitis B (Molecular Diagnostic Technique, Traditional Diagnostic Technique), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Disease Diagnostics.
Regionally, the report analyzes the Infectious Disease Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Disease Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infectious Disease Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Disease Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Molecular Diagnostic Technique, Traditional Diagnostic Technique).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Disease Diagnostics market.
Regional Analysis: The report involves examining the Infectious Disease Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Disease Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infectious Disease Diagnostics:
Company Analysis: Report covers individual Infectious Disease Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Disease Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis C, Hepatitis B).
Technology Analysis: Report covers specific technologies relevant to Infectious Disease Diagnostics. It assesses the current state, advancements, and potential future developments in Infectious Disease Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Disease Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Molecular Diagnostic Technique
- Traditional Diagnostic Technique
- Hepatitis C
- Hepatitis B
- Tuberculosis (TB)
- Acquired Immunodeficiency Syndrome (AIDS)
- Human Papillomavirus (HPV)
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Bio Mйrieux SA
- Roche Diagnostics
- Abbott Laboratories
- Thermo Fischer Scientific
- BD
- Bio-Rad Laboratories
- Abbott
- Danaher
- Johnson and Johnson
- Guangzhou Wondfo Biotech Co.,Ltd.
- Getein Biotech, Inc.
- Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
- BGI Genomics Co.,Ltd.
- Maccura Biotechnology Co.,Ltd.
- Daan Gene
- Beijing Strong Biotechnologies,Inc
- Shanghai Kehua Bio-Engineering Co.,Ltd.
- Guangdong Hybribio Biotech Co.,Ltd.
- Shanghai Runda Medical Technology Co.,Ltd.
- Tellgen Corporation
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin and global market share of Infectious Disease Diagnostics from 2019 to 2024.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Disease Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Diagnostics.
Chapter 13, to describe Infectious Disease Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Infectious Disease Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Disease Diagnostics by Type
1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Molecular Diagnostic Technique
1.3.4 Traditional Diagnostic Technique
1.4 Global Infectious Disease Diagnostics Market by Application
1.4.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hepatitis C
1.4.3 Hepatitis B
1.4.4 Tuberculosis (TB)
1.4.5 Acquired Immunodeficiency Syndrome (AIDS)
1.4.6 Human Papillomavirus (HPV)
1.4.7 Methicillin-resistant Staphylococcus Aureus (MRSA)
1.5 Global Infectious Disease Diagnostics Market Size & Forecast
1.6 Global Infectious Disease Diagnostics Market Size and Forecast by Region
1.6.1 Global Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infectious Disease Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bio Mйrieux SA
2.1.1 Bio Mйrieux SA Details
2.1.2 Bio Mйrieux SA Major Business
2.1.3 Bio Mйrieux SA Infectious Disease Diagnostics Product and Solutions
2.1.4 Bio Mйrieux SA Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bio Mйrieux SA Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
2.2.4 Roche Diagnostics Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
2.3.4 Abbott Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Thermo Fischer Scientific
2.4.1 Thermo Fischer Scientific Details
2.4.2 Thermo Fischer Scientific Major Business
2.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
2.4.4 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Infectious Disease Diagnostics Product and Solutions
2.5.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
2.6.4 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Infectious Disease Diagnostics Product and Solutions
2.7.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Infectious Disease Diagnostics Product and Solutions
2.8.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
2.9.4 Johnson and Johnson Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 Guangzhou Wondfo Biotech Co.,Ltd.
2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
2.11 Getein Biotech, Inc.
2.11.1 Getein Biotech, Inc. Details
2.11.2 Getein Biotech, Inc. Major Business
2.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
2.11.4 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Getein Biotech, Inc. Recent Developments and Future Plans
2.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
2.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Details
2.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
2.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
2.13 BGI Genomics Co.,Ltd.
2.13.1 BGI Genomics Co.,Ltd. Details
2.13.2 BGI Genomics Co.,Ltd. Major Business
2.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.13.4 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
2.14 Maccura Biotechnology Co.,Ltd.
2.14.1 Maccura Biotechnology Co.,Ltd. Details
2.14.2 Maccura Biotechnology Co.,Ltd. Major Business
2.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.14.4 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
2.15 Daan Gene
2.15.1 Daan Gene Details
2.15.2 Daan Gene Major Business
2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Daan Gene Recent Developments and Future Plans
2.16 Beijing Strong Biotechnologies,Inc
2.16.1 Beijing Strong Biotechnologies,Inc Details
2.16.2 Beijing Strong Biotechnologies,Inc Major Business
2.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
2.16.4 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
2.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
2.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Details
2.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
2.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
2.18 Guangdong Hybribio Biotech Co.,Ltd.
2.18.1 Guangdong Hybribio Biotech Co.,Ltd. Details
2.18.2 Guangdong Hybribio Biotech Co.,Ltd. Major Business
2.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.18.4 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
2.19 Shanghai Runda Medical Technology Co.,Ltd.
2.19.1 Shanghai Runda Medical Technology Co.,Ltd. Details
2.19.2 Shanghai Runda Medical Technology Co.,Ltd. Major Business
2.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.19.4 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
2.20 Tellgen Corporation
2.20.1 Tellgen Corporation Details
2.20.2 Tellgen Corporation Major Business
2.20.3 Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
2.20.4 Tellgen Corporation Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Tellgen Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Infectious Disease Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Disease Diagnostics Players Market Share in 2023
3.2.3 Top 6 Infectious Disease Diagnostics Players Market Share in 2023
3.3 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Disease Diagnostics Market: Region Footprint
3.3.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Disease Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Infectious Disease Diagnostics Market Drivers
11.2 Infectious Disease Diagnostics Market Restraints
11.3 Infectious Disease Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Disease Diagnostics Industry Chain
12.2 Infectious Disease Diagnostics Upstream Analysis
12.3 Infectious Disease Diagnostics Midstream Analysis
12.4 Infectious Disease Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Infectious Disease Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Disease Diagnostics by Type
1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Molecular Diagnostic Technique
1.3.4 Traditional Diagnostic Technique
1.4 Global Infectious Disease Diagnostics Market by Application
1.4.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hepatitis C
1.4.3 Hepatitis B
1.4.4 Tuberculosis (TB)
1.4.5 Acquired Immunodeficiency Syndrome (AIDS)
1.4.6 Human Papillomavirus (HPV)
1.4.7 Methicillin-resistant Staphylococcus Aureus (MRSA)
1.5 Global Infectious Disease Diagnostics Market Size & Forecast
1.6 Global Infectious Disease Diagnostics Market Size and Forecast by Region
1.6.1 Global Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infectious Disease Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infectious Disease Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bio Mйrieux SA
2.1.1 Bio Mйrieux SA Details
2.1.2 Bio Mйrieux SA Major Business
2.1.3 Bio Mйrieux SA Infectious Disease Diagnostics Product and Solutions
2.1.4 Bio Mйrieux SA Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bio Mйrieux SA Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
2.2.4 Roche Diagnostics Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
2.3.4 Abbott Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Thermo Fischer Scientific
2.4.1 Thermo Fischer Scientific Details
2.4.2 Thermo Fischer Scientific Major Business
2.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
2.4.4 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Infectious Disease Diagnostics Product and Solutions
2.5.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
2.6.4 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Infectious Disease Diagnostics Product and Solutions
2.7.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Infectious Disease Diagnostics Product and Solutions
2.8.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
2.9.4 Johnson and Johnson Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 Guangzhou Wondfo Biotech Co.,Ltd.
2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
2.11 Getein Biotech, Inc.
2.11.1 Getein Biotech, Inc. Details
2.11.2 Getein Biotech, Inc. Major Business
2.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
2.11.4 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Getein Biotech, Inc. Recent Developments and Future Plans
2.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
2.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Details
2.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
2.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
2.13 BGI Genomics Co.,Ltd.
2.13.1 BGI Genomics Co.,Ltd. Details
2.13.2 BGI Genomics Co.,Ltd. Major Business
2.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.13.4 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
2.14 Maccura Biotechnology Co.,Ltd.
2.14.1 Maccura Biotechnology Co.,Ltd. Details
2.14.2 Maccura Biotechnology Co.,Ltd. Major Business
2.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.14.4 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
2.15 Daan Gene
2.15.1 Daan Gene Details
2.15.2 Daan Gene Major Business
2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Daan Gene Recent Developments and Future Plans
2.16 Beijing Strong Biotechnologies,Inc
2.16.1 Beijing Strong Biotechnologies,Inc Details
2.16.2 Beijing Strong Biotechnologies,Inc Major Business
2.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
2.16.4 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
2.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
2.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Details
2.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
2.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
2.18 Guangdong Hybribio Biotech Co.,Ltd.
2.18.1 Guangdong Hybribio Biotech Co.,Ltd. Details
2.18.2 Guangdong Hybribio Biotech Co.,Ltd. Major Business
2.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.18.4 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
2.19 Shanghai Runda Medical Technology Co.,Ltd.
2.19.1 Shanghai Runda Medical Technology Co.,Ltd. Details
2.19.2 Shanghai Runda Medical Technology Co.,Ltd. Major Business
2.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.19.4 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
2.20 Tellgen Corporation
2.20.1 Tellgen Corporation Details
2.20.2 Tellgen Corporation Major Business
2.20.3 Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
2.20.4 Tellgen Corporation Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Tellgen Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Infectious Disease Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Disease Diagnostics Players Market Share in 2023
3.2.3 Top 6 Infectious Disease Diagnostics Players Market Share in 2023
3.3 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Disease Diagnostics Market: Region Footprint
3.3.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Disease Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Infectious Disease Diagnostics Market Drivers
11.2 Infectious Disease Diagnostics Market Restraints
11.3 Infectious Disease Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Disease Diagnostics Industry Chain
12.2 Infectious Disease Diagnostics Upstream Analysis
12.3 Infectious Disease Diagnostics Midstream Analysis
12.4 Infectious Disease Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Infectious Disease Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Infectious Disease Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bio Mйrieux SA Company Information, Head Office, and Major Competitors
Table 6. Bio Mйrieux SA Major Business
Table 7. Bio Mйrieux SA Infectious Disease Diagnostics Product and Solutions
Table 8. Bio Mйrieux SA Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bio Mйrieux SA Recent Developments and Future Plans
Table 10. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
Table 13. Roche Diagnostics Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Diagnostics Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
Table 18. Abbott Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. Thermo Fischer Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fischer Scientific Major Business
Table 22. Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
Table 23. Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fischer Scientific Recent Developments and Future Plans
Table 25. BD Company Information, Head Office, and Major Competitors
Table 26. BD Major Business
Table 27. BD Infectious Disease Diagnostics Product and Solutions
Table 28. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
Table 33. Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. Abbott Company Information, Head Office, and Major Competitors
Table 36. Abbott Major Business
Table 37. Abbott Infectious Disease Diagnostics Product and Solutions
Table 38. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbott Recent Developments and Future Plans
Table 40. Danaher Company Information, Head Office, and Major Competitors
Table 41. Danaher Major Business
Table 42. Danaher Infectious Disease Diagnostics Product and Solutions
Table 43. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Danaher Recent Developments and Future Plans
Table 45. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 46. Johnson and Johnson Major Business
Table 47. Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
Table 48. Johnson and Johnson Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Johnson and Johnson Recent Developments and Future Plans
Table 50. Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 51. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 52. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 53. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
Table 55. Getein Biotech, Inc. Company Information, Head Office, and Major Competitors
Table 56. Getein Biotech, Inc. Major Business
Table 57. Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
Table 58. Getein Biotech, Inc. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Getein Biotech, Inc. Recent Developments and Future Plans
Table 60. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 61. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
Table 62. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 63. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
Table 65. BGI Genomics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 66. BGI Genomics Co.,Ltd. Major Business
Table 67. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 68. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. BGI Genomics Co.,Ltd. Recent Developments and Future Plans
Table 70. Maccura Biotechnology Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 71. Maccura Biotechnology Co.,Ltd. Major Business
Table 72. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 73. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
Table 75. Daan Gene Company Information, Head Office, and Major Competitors
Table 76. Daan Gene Major Business
Table 77. Daan Gene Infectious Disease Diagnostics Product and Solutions
Table 78. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Daan Gene Recent Developments and Future Plans
Table 80. Beijing Strong Biotechnologies,Inc Company Information, Head Office, and Major Competitors
Table 81. Beijing Strong Biotechnologies,Inc Major Business
Table 82. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
Table 83. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
Table 85. Shanghai Kehua Bio-Engineering Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 86. Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
Table 87. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 88. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
Table 90. Guangdong Hybribio Biotech Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 91. Guangdong Hybribio Biotech Co.,Ltd. Major Business
Table 92. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 93. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
Table 95. Shanghai Runda Medical Technology Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 96. Shanghai Runda Medical Technology Co.,Ltd. Major Business
Table 97. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 98. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
Table 100. Tellgen Corporation Company Information, Head Office, and Major Competitors
Table 101. Tellgen Corporation Major Business
Table 102. Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
Table 103. Tellgen Corporation Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Tellgen Corporation Recent Developments and Future Plans
Table 105. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 106. Global Infectious Disease Diagnostics Revenue Share by Players (2019-2024)
Table 107. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Infectious Disease Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Infectious Disease Diagnostics Players
Table 110. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 111. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 112. Infectious Disease Diagnostics New Market Entrants and Barriers to Market Entry
Table 113. Infectious Disease Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Infectious Disease Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Infectious Disease Diagnostics Consumption Value Share by Type (2019-2024)
Table 116. Global Infectious Disease Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 117. Global Infectious Disease Diagnostics Consumption Value by Application (2019-2024)
Table 118. Global Infectious Disease Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 119. North America Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Infectious Disease Diagnostics Raw Material
Table 150. Key Suppliers of Infectious Disease Diagnostics Raw Materials
Table 1. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Infectious Disease Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Infectious Disease Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bio Mйrieux SA Company Information, Head Office, and Major Competitors
Table 6. Bio Mйrieux SA Major Business
Table 7. Bio Mйrieux SA Infectious Disease Diagnostics Product and Solutions
Table 8. Bio Mйrieux SA Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bio Mйrieux SA Recent Developments and Future Plans
Table 10. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
Table 13. Roche Diagnostics Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Diagnostics Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
Table 18. Abbott Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. Thermo Fischer Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fischer Scientific Major Business
Table 22. Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
Table 23. Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fischer Scientific Recent Developments and Future Plans
Table 25. BD Company Information, Head Office, and Major Competitors
Table 26. BD Major Business
Table 27. BD Infectious Disease Diagnostics Product and Solutions
Table 28. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
Table 33. Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. Abbott Company Information, Head Office, and Major Competitors
Table 36. Abbott Major Business
Table 37. Abbott Infectious Disease Diagnostics Product and Solutions
Table 38. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbott Recent Developments and Future Plans
Table 40. Danaher Company Information, Head Office, and Major Competitors
Table 41. Danaher Major Business
Table 42. Danaher Infectious Disease Diagnostics Product and Solutions
Table 43. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Danaher Recent Developments and Future Plans
Table 45. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 46. Johnson and Johnson Major Business
Table 47. Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
Table 48. Johnson and Johnson Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Johnson and Johnson Recent Developments and Future Plans
Table 50. Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 51. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 52. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 53. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
Table 55. Getein Biotech, Inc. Company Information, Head Office, and Major Competitors
Table 56. Getein Biotech, Inc. Major Business
Table 57. Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
Table 58. Getein Biotech, Inc. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Getein Biotech, Inc. Recent Developments and Future Plans
Table 60. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 61. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
Table 62. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 63. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
Table 65. BGI Genomics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 66. BGI Genomics Co.,Ltd. Major Business
Table 67. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 68. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. BGI Genomics Co.,Ltd. Recent Developments and Future Plans
Table 70. Maccura Biotechnology Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 71. Maccura Biotechnology Co.,Ltd. Major Business
Table 72. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 73. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
Table 75. Daan Gene Company Information, Head Office, and Major Competitors
Table 76. Daan Gene Major Business
Table 77. Daan Gene Infectious Disease Diagnostics Product and Solutions
Table 78. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Daan Gene Recent Developments and Future Plans
Table 80. Beijing Strong Biotechnologies,Inc Company Information, Head Office, and Major Competitors
Table 81. Beijing Strong Biotechnologies,Inc Major Business
Table 82. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
Table 83. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
Table 85. Shanghai Kehua Bio-Engineering Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 86. Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
Table 87. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 88. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
Table 90. Guangdong Hybribio Biotech Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 91. Guangdong Hybribio Biotech Co.,Ltd. Major Business
Table 92. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 93. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
Table 95. Shanghai Runda Medical Technology Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 96. Shanghai Runda Medical Technology Co.,Ltd. Major Business
Table 97. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 98. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
Table 100. Tellgen Corporation Company Information, Head Office, and Major Competitors
Table 101. Tellgen Corporation Major Business
Table 102. Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
Table 103. Tellgen Corporation Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Tellgen Corporation Recent Developments and Future Plans
Table 105. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 106. Global Infectious Disease Diagnostics Revenue Share by Players (2019-2024)
Table 107. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Infectious Disease Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Infectious Disease Diagnostics Players
Table 110. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 111. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 112. Infectious Disease Diagnostics New Market Entrants and Barriers to Market Entry
Table 113. Infectious Disease Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Infectious Disease Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Infectious Disease Diagnostics Consumption Value Share by Type (2019-2024)
Table 116. Global Infectious Disease Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 117. Global Infectious Disease Diagnostics Consumption Value by Application (2019-2024)
Table 118. Global Infectious Disease Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 119. North America Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Infectious Disease Diagnostics Raw Material
Table 150. Key Suppliers of Infectious Disease Diagnostics Raw Materials
LIST OF FIGURES
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Molecular Diagnostic Technique
Figure 5. Traditional Diagnostic Technique
Figure 6. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Infectious Disease Diagnostics Consumption Value Market Share by Application in 2023
Figure 8. Hepatitis C Picture
Figure 9. Hepatitis B Picture
Figure 10. Tuberculosis (TB) Picture
Figure 11. Acquired Immunodeficiency Syndrome (AIDS) Picture
Figure 12. Human Papillomavirus (HPV) Picture
Figure 13. Methicillin-resistant Staphylococcus Aureus (MRSA) Picture
Figure 14. Global Infectious Disease Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Infectious Disease Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Infectious Disease Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Infectious Disease Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Infectious Disease Diagnostics Consumption Value Market Share by Region in 2023
Figure 19. North America Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Infectious Disease Diagnostics Revenue Share by Players in 2023
Figure 25. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Infectious Disease Diagnostics Market Share in 2023
Figure 27. Global Top 6 Players Infectious Disease Diagnostics Market Share in 2023
Figure 28. Global Infectious Disease Diagnostics Consumption Value Share by Type (2019-2024)
Figure 29. Global Infectious Disease Diagnostics Market Share Forecast by Type (2025-2030)
Figure 30. Global Infectious Disease Diagnostics Consumption Value Share by Application (2019-2024)
Figure 31. Global Infectious Disease Diagnostics Market Share Forecast by Application (2025-2030)
Figure 32. North America Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 66. Infectious Disease Diagnostics Market Drivers
Figure 67. Infectious Disease Diagnostics Market Restraints
Figure 68. Infectious Disease Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Infectious Disease Diagnostics in 2023
Figure 71. Manufacturing Process Analysis of Infectious Disease Diagnostics
Figure 72. Infectious Disease Diagnostics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Molecular Diagnostic Technique
Figure 5. Traditional Diagnostic Technique
Figure 6. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Infectious Disease Diagnostics Consumption Value Market Share by Application in 2023
Figure 8. Hepatitis C Picture
Figure 9. Hepatitis B Picture
Figure 10. Tuberculosis (TB) Picture
Figure 11. Acquired Immunodeficiency Syndrome (AIDS) Picture
Figure 12. Human Papillomavirus (HPV) Picture
Figure 13. Methicillin-resistant Staphylococcus Aureus (MRSA) Picture
Figure 14. Global Infectious Disease Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Infectious Disease Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Infectious Disease Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Infectious Disease Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Infectious Disease Diagnostics Consumption Value Market Share by Region in 2023
Figure 19. North America Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Infectious Disease Diagnostics Revenue Share by Players in 2023
Figure 25. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Infectious Disease Diagnostics Market Share in 2023
Figure 27. Global Top 6 Players Infectious Disease Diagnostics Market Share in 2023
Figure 28. Global Infectious Disease Diagnostics Consumption Value Share by Type (2019-2024)
Figure 29. Global Infectious Disease Diagnostics Market Share Forecast by Type (2025-2030)
Figure 30. Global Infectious Disease Diagnostics Consumption Value Share by Application (2019-2024)
Figure 31. Global Infectious Disease Diagnostics Market Share Forecast by Application (2025-2030)
Figure 32. North America Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Infectious Disease Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Infectious Disease Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 66. Infectious Disease Diagnostics Market Drivers
Figure 67. Infectious Disease Diagnostics Market Restraints
Figure 68. Infectious Disease Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Infectious Disease Diagnostics in 2023
Figure 71. Manufacturing Process Analysis of Infectious Disease Diagnostics
Figure 72. Infectious Disease Diagnostics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
